BiondVax Pharmaceuticals

$3.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-5.74%) As of 10:21 AM EDT today

Why Robinhood?

You can buy or sell BVXV and other stocks, options, and ETFs commission-free!

About BVXV

BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel. The listed name for BVXV is BiondVax Pharmaceuticals Ltd. American Depositary Shares.

Employees
25
Headquarters
Jerusalem, Jerusalem
Founded
2003
Market Cap
39.35M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.60M
High Today
$3.54
Low Today
$2.81
Open Price
$2.93
Volume
1.17M
52 Week High
$62.00
52 Week Low
$2.81

Collections

BVXV Earnings

-$0.05
-$0.03
-$0.02
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 24, Pre-Market

You May Also Like